Applied Therapeutics Receives Complete Response Letter From U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

GlobeNewswireNov 27 16:10 ET

Applied Therapeutics Price Target Lowered to $5 From $14 at Baird

TipRanks16minutes ago

Applied Therapeutics' Govorestat Faces Unclear Regulatory Path After FDA Rejection, RBC Says

MT Newswires20minutes ago

Stock market anomaly | applied therapeutics (APLT.US) opened sharply down 76%, a record decline.

On Friday, applied therapeutics (APLT.US) opened with a sharp decline of 76%, setting a record drop, with a market cap of less than 0.3 billion dollars and a stock price of 2.12 dollars.

Zhitong Finance21minutes ago

Express News | Applied Therapeutics Shares Drop 75% After U.S. FDA Declines to Approve Co's Genetic Disease Drug

Reuters23minutes ago

Sector Update: Health Care Stocks Advance Pre-Bell Friday

MT Newswires44minutes ago